The fate of the aortofemoral graft

Eur J Vasc Endovasc Surg. 1995 Jan;9(1):97-102. doi: 10.1016/s1078-5884(05)80232-1.

Abstract

Objective: To determine the incidence and cause for reoperation following aortofemoral bypass surgery.

Design: This paper describes the results of all aortofemoral grafts performed in the years 1978-1991, 251 of these patients underwent an aortobifemoral graft (ABF) whilst the remaining 50 had an aortounifemoral graft (AUF).

Results: The aortofemoral bypass was the only operation performed in fewer than half of the patients. Sixteen per cent of ABF and 50% of the AUF patients had surgery before the index operation. Subsequently 33% of the ABF patients and 60% of the AUF group had one or more additional vascular procedures. Graft infections and false aneurysms continued to present in about 1% patients per year at least up to 10 years following surgery. The 5 year actuarial survival was 73% in the ABF group and 38% in the AUF patients. The primary patency at 5 years was 85% in the ABF patients and 81% in the AUF group. Amputation was performed in 6% of the ABF patients and in 20% of the AUF patients.

Conclusions: The frequent need for later surgery (1:3 for the ABF patients) should be considered in the decision to undertake the initial aortofemoral operation when the patient presents with intermittent claudication.

MeSH terms

  • Aneurysm, False / epidemiology
  • Aneurysm, False / surgery
  • Aorta, Abdominal / surgery
  • Arteriovenous Shunt, Surgical*
  • Blood Vessel Prosthesis*
  • Female
  • Femoral Artery / surgery
  • Follow-Up Studies
  • Humans
  • Iliac Artery / surgery
  • Incidence
  • Intermittent Claudication / epidemiology
  • Intermittent Claudication / surgery*
  • Male
  • Middle Aged
  • Morbidity
  • Postoperative Complications / epidemiology*
  • Postoperative Complications / surgery
  • Reoperation / statistics & numerical data
  • Time Factors
  • Treatment Outcome
  • Vascular Patency